title: Cognitive function paradigms: implications of neurophysiological studies of dopamine stimulants for Tourette syndrome and comorbid attention-deficit hyperactivity disorder.
authors.affiliation: Neurophysiological Pharmacology Section, Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
authors.forename: J R
authors.initials: JR
authors.lastname: Walters
authors.forename: D N
authors.initials: DN
authors.lastname: Ruskin
authors.forename: D
authors.initials: D
authors.lastname: Baek
authors.forename: K A
authors.initials: KA
authors.lastname: Allers
authors.forename: D A
authors.initials: DA
authors.lastname: Bergstrom
mesh_terms: D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D003072:Cognition Disorders / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D018491:Dopamine Agonists / Q000627:therapeutic use*; D006801:Humans; D005879:Tourette Syndrome / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D018491:Dopamine Agonists